This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPED0C0KP_M.jpgHowever, not all ETFs experienced similar success on Thursday. The ARK Genomic Revolution ETF underperformed compared to its counterparts, recording a decline of roughly 0.6%. This downturn was largely attributed to weak performances from component companies such as Twist Bioscience (NASDAQ:TWST) and Guardant Health (NASDAQ:GH). Shares of Twist Bioscience fell by approximately 5.8%, while shares of Guardant Health dipped by around 4.8%.
The marked shift in performances across different sectors on Thursday underscores the need for investors to stay updated with the latest news, strategies, and tips to make informed investment decisions. The contrasting performance of the iShares MSCI Global Metals & Mining Producers ETF and the ARK Genomic Revolution ETF serves as a reminder of the variability inherent in market movements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.